| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/13/2000 | WO2000040742A1 Use of the cell's own transport system for transferring nucleic acids across the nuclear membrane |
| 07/13/2000 | WO2000040738A1 Co-expression of proteins |
| 07/13/2000 | WO2000040730A1 POLYHYDROXYALKANOATE BIOSYNTHESIS ASSOCIATED PROTEINS AND CODING REGION IN $i(BACILLUS MEGATERIUM) |
| 07/13/2000 | WO2000040729A1 Streptococcal abc transporter protein |
| 07/13/2000 | WO2000040728A1 Nucleic acids and proteins corresponding to mutants of g-csf with granulopoietic activity |
| 07/13/2000 | WO2000040727A2 Recombinant growth factor with the biological activity of a g-csf (granulocyte colony stimulating factor) |
| 07/13/2000 | WO2000040726A1 Human chemokine beta-10 mutant polypeptides |
| 07/13/2000 | WO2000040724A1 Human seven-transmembrane receptors |
| 07/13/2000 | WO2000040723A2 Methods and products for delivering nucleic acids |
| 07/13/2000 | WO2000040722A2 Insulin-synthesis genes |
| 07/13/2000 | WO2000040721A1 Monocyte-derived nucleic acids and related compositions and methods |
| 07/13/2000 | WO2000040719A2 Tissue repair protein involved in orofacial clefting and uses thereof |
| 07/13/2000 | WO2000040718A2 MUTANTS OF GNRPs AND VECTORS SUITABLE FOR THEIR EXPRESSION |
| 07/13/2000 | WO2000040717A1 Method for the cellular high-throughput-detection of nuclear receptor ligand interactions |
| 07/13/2000 | WO2000040716A2 Soluble receptor br43x2 and methods of using them for therapy |
| 07/13/2000 | WO2000040711A2 Polycystic kidney disease gene homologs required for male mating behavior in nematodes and assays based thereon |
| 07/13/2000 | WO2000040710A2 Seed-preferred promoter |
| 07/13/2000 | WO2000040700A2 Oocyte activation by sperm components |
| 07/13/2000 | WO2000040698A1 Pth receptor and screening assay utilizing the same |
| 07/13/2000 | WO2000040695A2 Sequence-determined dna fragments and corresponding polypeptides encoded thereby |
| 07/13/2000 | WO2000040694A2 Methods for altering organ mass, controlling fertility and enhancing asexual reproduction in plants |
| 07/13/2000 | WO2000040693A2 Expression of secreted human alpha-fetoprotein in transgenic animals |
| 07/13/2000 | WO2000040616A1 METHODS OF ELICITING BROADLY NEUTRALIZING ANTIBODIES TARGETING HIV-1 gp41 |
| 07/13/2000 | WO2000040615A2 EXPRESSION AND EXPORT OF ANTI-OBESITY PROTEINS AS Fc FUSION PROTEINS |
| 07/13/2000 | WO2000040614A2 Characterization of the soc/crac calcium channel protein family |
| 07/13/2000 | WO2000040613A1 Insulin-like growth factor (igf) i mutant variants |
| 07/13/2000 | WO2000040612A1 Insulin-like growth factor (igf) i mutant variants |
| 07/13/2000 | WO2000040611A1 Slimming cosmetic compositions |
| 07/13/2000 | WO2000040610A1 Process for producing activated protein |
| 07/13/2000 | WO2000040609A1 Novel protein |
| 07/13/2000 | WO2000040608A1 Proteins from rana pipiens and their use in the treatment of tumors |
| 07/13/2000 | WO2000040607A2 Tiam2 (t-cell lymphoma invasion and metastasis 2) nucleotide exchange factor |
| 07/13/2000 | WO2000040606A2 Modulation of hiv replication using sam68 |
| 07/13/2000 | WO2000040604A2 METHODS AND COMPOSITIONS FOR MODULATING CYTOKINE RELEASE BY αEβ7-EXPRESSING CELLS |
| 07/13/2000 | WO2000040603A2 Production of recombinant monellin using methylotrophic yeast expression system |
| 07/13/2000 | WO2000040602A1 Binding molecules for human factor viii and factor viii-like proteins |
| 07/13/2000 | WO2000040274A1 Metastasis models using green fluorescent protein (gfp) as a marker |
| 07/13/2000 | WO2000040263A1 Production and use of a composition containing ivig for treating diseases that are characterized by elevated extracellular fasl titers |
| 07/13/2000 | WO2000040253A1 Synthetic, highly charged molecules and uses thereof |
| 07/13/2000 | WO2000040204A2 Methods for treating cystic fibrosis |
| 07/13/2000 | WO2000031268B1 Maize rad23 genes and uses thereof |
| 07/13/2000 | WO2000026392A3 MUTANT MOUSE CONTAINING A KNOCKOUT MUTATION IN DNA ENCODING AN ENDOGENOUS α4 SUBUNIT OF NICOTINIC ACETYLCHOLINE RECEPTOR |
| 07/13/2000 | WO2000026339A3 Axor14, a g-protein coupled receptor |
| 07/13/2000 | WO2000026242A9 Dna replication-regulating genes, antibodies thereto and diagnostic applications thereof |
| 07/13/2000 | WO2000025815A8 Novel immunoadjuvants |
| 07/13/2000 | WO2000024914A3 Apomixis conferred by expression of serk interacting proteins |
| 07/13/2000 | WO2000024897B1 Cell surface molecule-induced macrophage activation |
| 07/13/2000 | WO2000022121A3 Ion channels, in particular vanilloid receptor-like (vr-l) receptor |
| 07/13/2000 | WO2000022118A3 Non-desensitizing ampa-receptors |
| 07/13/2000 | WO2000022092A3 Materials and methods for the modification of plant cell wall polysaccharides |
| 07/13/2000 | WO2000021987A3 A method of identifying modulators of cell surface membrane receptors useful in the treatment of disease |
| 07/13/2000 | WO2000021986A3 Matrix-remodeling genes |
| 07/13/2000 | WO2000020445A3 Tumor antigens and ctl clones isolated by a novel procedure |
| 07/13/2000 | WO2000018801A3 Ncam binding compounds |
| 07/13/2000 | WO2000018433A3 Use of antigenic complexes of hiv envelope and hla class i antigens as hiv vaccine |
| 07/13/2000 | WO2000017364A3 Cyclin d polynucleotides, polypeptides and uses thereof |
| 07/13/2000 | WO2000015800A3 Rac-like genes and methods of use |
| 07/13/2000 | WO2000015799A3 Rna-associated proteins |
| 07/13/2000 | WO2000015175A3 Use as an active substance of molecules binding to beta-1-integrin with the capacity to kill cells |
| 07/13/2000 | WO2000012735A9 Transgene assay using stable agrobacterium rhizogenes transformation |
| 07/13/2000 | WO2000012705A9 Methods for improving the function of heterologous g protein-coupled receptors |
| 07/13/2000 | WO2000012128A3 Recombinant subunit vaccine against flaviviral infection |
| 07/13/2000 | WO2000011148A3 Cold-shock regulatory elements, constructs thereof, and methods of use |
| 07/13/2000 | WO2000009734A9 Methods and compositions for use in spliceosome mediated rna trans-splicing |
| 07/13/2000 | WO2000009666A9 Differentiation of non-insulin producing cells into insulin producing cells by glp-1 or exendin-4 and uses thereof |
| 07/13/2000 | WO2000008153A9 Arf-p19, a novel regulator of the mammalian cell cycle |
| 07/13/2000 | WO2000007545A9 Apoptosis proteins |
| 07/13/2000 | WO2000004151A3 Identification and characterization of splice variants of kappa3-related opioid receptor (kor3) gene |
| 07/13/2000 | WO2000002997A3 Transgenic mouse expressing green fluorescent protein in astrocytes |
| 07/13/2000 | WO2000002524A9 Botulinum neurotoxin vaccine |
| 07/13/2000 | WO1999066324A9 A bioluminescence resonance energy transfer (bret) system and its use |
| 07/13/2000 | WO1999061579A3 MarA FAMILY HELIX-TURN-HELIX DOMAINS AND THEIR METHODS OF USE |
| 07/13/2000 | WO1999060016A3 Antimicrobial cationic peptide derivatives of bactenecin |
| 07/13/2000 | WO1997020575A8 Targeted adenovirus vectors |
| 07/13/2000 | DE19933939A1 Ausnutzung zelleigener Transportsysteme zum Transfer von Nukleinsäuren durch die Kernhülle Utilization of cellular transport systems for the transfer of nucleic acids by the nuclear envelope |
| 07/13/2000 | DE19917838A1 Composition for treating prion or other neurodegenerative diseases, comprises a peptide that inhibits unfolding of the prion to its pathological isoform |
| 07/13/2000 | DE19900743A1 Neue komplexbildende Proteine New complexing proteins |
| 07/13/2000 | DE19900635A1 Selektion von monoklonalen Antikörpern Selection of monoclonal antibodies |
| 07/13/2000 | DE19900503A1 Verwendung einer Zusammensetzung zur Herstellung eines Arzneimittels zur Behandlung von Erkrankungen mit erhöhten extrazellulären FasL-Titern, Verfahren zur prophylaktischen Eignungs- bzw. Qualitätskontrolle derselben, Verfahren zur Herstellung von Arzneimitteln zur Behandlung obiger Krankheiten mit gesteigerter Wirksamkeit Use of a composition for the manufacture of a medicament for the treatment of diseases with increased extracellular FasL titers method for the prophylactic or suitability quality control thereof, a process for the preparation of medicaments for the treatment of the above diseases with enhanced efficacy |
| 07/13/2000 | DE19847074C1 Verfahren zum Entfernen von Lipopolysacchariden aus wäßrigen, proteinhaltigen Lösungen A method for removing lipopolysaccharides from aqueous, protein-containing solutions |
| 07/13/2000 | CA2753331A1 Soluble receptor br43x2 and methods of using |
| 07/13/2000 | CA2702760A1 Insulin-like growth factor (igf) i mutant variants |
| 07/13/2000 | CA2364005A1 Production of recombinant monellin using methylotrophic yeast expression system |
| 07/13/2000 | CA2363839A1 Wound healing and orofacial clefting |
| 07/13/2000 | CA2363803A1 Polyhydroxyalkanoate biosynthesis associated proteins and coding region in bacillus megaterium |
| 07/13/2000 | CA2360407A1 Sequence-determined dna fragments and corresponding polypeptides encoded thereby |
| 07/13/2000 | CA2360396A1 Characterization of a calcium channel family |
| 07/13/2000 | CA2360381A1 Methods for treating cystic fibrosis |
| 07/13/2000 | CA2359892A1 Methods of eliciting broadly neutralizing antibodies targeting hiv-1 gp41 |
| 07/13/2000 | CA2359853A1 Human chemokine beta-10 mutant polypeptides |
| 07/13/2000 | CA2358609A1 Process for producing activated protein |
| 07/13/2000 | CA2358562A1 Monocyte-derived nucleic acids and related compositions and methods |
| 07/13/2000 | CA2358548A1 Co-expression of proteins |
| 07/13/2000 | CA2358285A1 Method and kit for extracting prion protein |
| 07/13/2000 | CA2358102A1 Detecting and monitoring hiv viral infections |
| 07/13/2000 | CA2357996A1 Streptococcal abc transporter protein |
| 07/13/2000 | CA2357811A1 Nucleic acids and proteins corresponding to mutants of g-csf with granulopoietic activity |
| 07/13/2000 | CA2357807A1 Human seven-transmembrane receptors |
| 07/13/2000 | CA2357677A1 Insulin-synthesis genes |
| 07/13/2000 | CA2356401A1 Expression and export of anti-obesity proteins as fc fusion proteins |